Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanomedicines’ impact on patients under the microscope: A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic

Abstract:
A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic.

Nanomedicines’ impact on patients under the microscope: A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic

Glasgow, UK | Posted on May 29th, 2013

Professor Dr. M. N. V. Ravi Kumar and Dr. Dimitrios Lamprou, of the Strathclyde Institute of Pharmacy and Biomedical Sciences, believe an advanced form of atomic force microscopy, known as PeakForce QNM, could boost developments in the field of nanomedicines, the encapsulation of potent drugs in tiny particles measuring billionths of a meter in diameter. They described how this detailed imaging approach may also help scientists address growing concerns in the medical world around "nanotoxicology", the build-up of microscopic particles in people's tissues.

Professor Kumar, whose team's research article has been published in the journal PLOS ONE, said: "Nanotechnology's role in drug delivery has the power to transform the way patients are given medicines over the next decade or so.

"In the case of traditional medicines, such as tablets and capsules, only a limited amount of drug - thought to be around five to 15 per cent for the majority of compounds - makes it through the gut into patients' blood. The good thing about nanomedicines is that - unlike as is the case with traditional tablets and capsules - the drugs are not released in the gut. Instead, nanomedicines are absorbed intact and release the encapsulated drugs directly into bodily tissues, including the blood, offering the possibility to reduce the required dose without compromising the therapeutic effects.

"All medicines are combined with what are known as 'excipients' - inactive substances which give them the desired bulk and consistency and their role is restricted to the gut. However, the excipients such as polymers, used to formulate the nanoparticle-encapsulating drugs may exhibit undesired effects when they are absorbed through the gut wall. Scientists want to know if nanoparticle-based drugs can have any adverse effects on patients - and, in particular, if they cause more harm than good in some cases.

"Up until now, little has been known about what happens after nanoparticles circulate throughout the body and if they raise any safety issues for the patient. Previously, it was necessary for nanoparticles to be given a fluorescent or radioactive label, in order to allow scientists to be able to identify and track them. However, by using PeakForce QNM atomic force microscopy we can, for the first time, track where these nanoparticles are going throughout the body after oral administration - without attaching any fluorescent or radioactive labels and by using the real drug loaded nanoparticles. In particular, we can identify if they are accumulating in specific areas, causing what is known as 'tissue stiffness' - a condition linked to a variety of diseases, including cancer."

Professor Kumar said it is known that tumours are more rigid - or stiff - when compared with surrounding healthy tissues. In addition, recent studies using atomic force microscopy have also shown it is possible to distinguish between non-malignant and malignant tumours cells, on the basis of their relative stiffness.

Professor Kumar added: "The ability of atomic force microscopy to study biomechanical profiles will be an asset in efforts to better understand the difference in tissue stiffness between tissues treated with nanoparticles and those not treated with nanoparticles, how long any associated tissue stiffness persists, and if it disappears quickly. Importantly, it will also help to establish whether or not there is a correlation between the number of nanoparticles present in blood and their accumulation in other tissues. By understanding more about blood stiffness, we will be able to learn more about nanotoxicology generally, and how that affects patients.

"By using atomic force microscopy in this way, we may in future be able to analyse patients' blood and tell if, for example, nanomaterials are accumulating in their livers or arterial walls, causing stiffness which - if it persists long enough - may increase their chances of developing diseases.

"Another benefit of nanoparticles is that - if used at an early stage of the research - they could save pharmaceutical firms money by reducing the number of drugs that fail at the development stage. These cost savings could then be reinvested into the research and development of new drugs to treat patients."

####

About University of Strathclyde
The University of Strathclyde is a leading international technological university which is recognised for strong research links with business and industry, commitment to enterprise and skills development, and knowledge sharing with the private and public sectors. The University was named UK University of the Year in the 2012 Times Higher Education Awards.

For more information, please click here

Contacts:
Corporate Communications

44-014-154-82370

Copyright © University of Strathclyde

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

This link – can used to find the full PLOS ONE research article, "entitled Atomic Force Microscopy Images Label-Free, Drug Encapsulated Nanoparticles In Vivo and Detects Difference in Tissue Mechanical Properties of Treated and Untreated: A Tip for Nanotoxicology".

Related News Press

News and information

Gold shines through properties of nano biosensors: Researchers discover that fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves August 16th, 2017

Two Scientists Receive Grants to Develop New Materials: Chad Mirkin and Monica Olvera de la Cruz recognized by Sherman Fairchild Foundation August 16th, 2017

Fewer defects from a 2-D approach August 15th, 2017

Scientists from the University of Manchester and Diamond Light Source work with Deben to develop and test a new compression stage to study irradiated graphite at elevated temperatures August 15th, 2017

Imaging

Industry’s First Dedicated Cryo-DualBeam System Automates Preparation of Frozen, Biological Samples: New Thermo Scientific Aquilos FIB/SEM protects sample integrity and enhances productivity for cryo-electron tomography workflow August 8th, 2017

Thermo Fisher Scientific Advances Cryo-EM Leadership to Drive Structural Biology Discoveries: New Thermo Scientific Krios G3i raises bar for performance, automation and time-to-results Breakthrough Thermo Scientific Glacios provides a cryo-EM entry path for a broader range of res August 8th, 2017

New Quattro Field Emission ESEM Emphasizes Versatility and Ease of Use: Thermo Scientific Quattro ESEM allows materials science researchers to study nanoscale structure in almost any material under a range of environmental conditions August 8th, 2017

Thermo Fisher Scientific’s New Talos F200i S/TEM Delivers Flexible, High-Performance Imaging: New compact S/TEM can be configured to meet specific imaging and analytical requirements for materials characterization in research laboratories August 8th, 2017

Nanomedicine

Gold shines through properties of nano biosensors: Researchers discover that fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves August 16th, 2017

Two Scientists Receive Grants to Develop New Materials: Chad Mirkin and Monica Olvera de la Cruz recognized by Sherman Fairchild Foundation August 16th, 2017

JPK reports on how the University of Glasgow is using their NanoWizard® AFM and CellHesion module to study how cells interact with their surroundings August 2nd, 2017

Research team bends individual tetrapod nanostructures August 2nd, 2017

Discoveries

Gold shines through properties of nano biosensors: Researchers discover that fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves August 16th, 2017

Fewer defects from a 2-D approach August 15th, 2017

Scientists from the University of Manchester and Diamond Light Source work with Deben to develop and test a new compression stage to study irradiated graphite at elevated temperatures August 15th, 2017

2-faced 2-D material is a first at Rice: Rice University materials scientists create flat sandwich of sulfur, molybdenum and selenium August 14th, 2017

Announcements

Gold shines through properties of nano biosensors: Researchers discover that fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves August 16th, 2017

Two Scientists Receive Grants to Develop New Materials: Chad Mirkin and Monica Olvera de la Cruz recognized by Sherman Fairchild Foundation August 16th, 2017

Fewer defects from a 2-D approach August 15th, 2017

Scientists from the University of Manchester and Diamond Light Source work with Deben to develop and test a new compression stage to study irradiated graphite at elevated temperatures August 15th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project